Jan Schnalke

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 4

Top Topics

Dna Methylation

Health Insurance

Mesenchymal Stem Cells

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Johanna Risse, Merlin Krzemien, Jan Schnalke, Thomas Heinemann
Towards ethical drug pricing: the European Orphan Genomic Therapies Fund. Gene therapy (2024)
Johanna Risse, Merlin Krzemien, Jan Schnalke, Thomas Heinemann
Towards ethical drug pricing: the European Orphan Genomic Therapies Fund. Gene therapy 31 (7-8) (2024)
Johanna Risse, Merlin Krzemien, Jan Schnalke, Thomas Heinemann
Towards ethical drug pricing: the European Orphan Genomic Therapies Fund. Gene therapy 31 (7-8) (2024)
Johanna Risse, Merlin Krzemien, Jan Schnalke, Thomas Heinemann
Towards ethical drug pricing: the European Orphan Genomic Therapies Fund. Gene therapy 31 (7-8) (2024)